Q/C Technologies, Inc. Marketable Securities (Current)
Q/C Technologies, Inc. (QCLS) had Marketable Securities (Current) of $10.68 million as of 2026-06-30, per its 10-Q filed 2026-08-12.
Financial Statements › Balance Sheet › Assets › Assets, Current › Cash, Cash Equivalents, and Short-Term Investments
us-gaap:MarketableSecuritiesCurrent · last filed 2026-08-12
- 2026-06-30: Marketable Securities, Current $10.68M.
- 2026-03-31: Marketable Securities, Current $11.85M.
- 2025-12-31: Marketable Securities, Current $14.80M.
- 2025-09-30: Marketable Securities, Current $3.09M.
| Period end | Marketable Securities, Current |
|---|---|
| 2026-06-30 | $10.68M 10-Q · filed 2026-08-12 |
| 2026-03-31 | $11.85M 10-Q · filed 2026-05-15 |
| 2025-12-31 | $14.80M 10-Q · filed 2026-08-12 |
| 2025-09-30 | $3.09M 10-Q · filed 2025-11-19 |
| 2025-06-30 | $3.61M 10-Q · filed 2025-08-19 |
| 2025-03-31 | $5.81M 10-Q · filed 2025-05-15 |
| 2024-12-31 | $8.35M 10-K · filed 2026-04-15 |
| 2024-09-30 | $9.45M 10-Q · filed 2024-11-14 |
| 2024-06-30 | $12.53M 10-Q · filed 2024-08-19 |
| 2024-03-31 | $1.51M 10-Q · filed 2024-05-15 |
| 2023-12-31 | $2.24M 10-K · filed 2025-04-11 |
| 2023-09-30 | $8.17M 10-Q · filed 2023-11-14 |
| 2023-06-30 | $11.53M 10-Q · filed 2023-08-14 |
| 2023-03-31 | $15.36M 10-Q · filed 2023-05-15 |
| 2022-12-31 | $4.09M 10-K · filed 2024-04-01 |
| 2022-09-30 | $6.77M 10-Q · filed 2022-11-10 |
| 2022-06-30 | $4.51M 10-Q · filed 2022-08-15 |
| 2022-03-31 | $8.00M 10-Q · filed 2022-05-16 |
| 2021-12-31 | $11.00M 10-K · filed 2023-03-31 |
| 2021-09-30 | $14.00M 10-Q/A · filed 2021-11-15 |
| 2021-06-30 | $19.50M 10-Q · filed 2021-08-16 |
| 2021-03-31 | $30.48M 10-Q · filed 2021-05-18 |
| 2020-12-31 | $16.72M 10-Q · filed 2021-05-18 |
| 2020-09-30 | $6.93M 10-Q · filed 2020-11-16 |
| 2020-06-30 | $6.86M 10-Q · filed 2020-08-14 |
| 2020-03-31 | $6.63M 10-Q · filed 2020-05-15 |
| 2019-12-31 | $9.16M 10-K · filed 2021-03-01 |
| 2019-09-30 | $2.85M 10-Q · filed 2019-11-14 |
| 2019-06-30 | $4.02M 10-Q · filed 2019-08-14 |
| 2019-03-31 | $4.48M 10-Q · filed 2019-05-20 |
| 2018-12-31 | $5.27M 10-K · filed 2020-03-25 |
| 2018-09-30 | $4.87M 10-Q · filed 2018-11-14 |
| 2018-06-30 | $7.98M 10-Q · filed 2018-08-14 |
| 2018-03-31 | $8.68M 10-Q · filed 2018-07-13 |
| 2017-12-31 | $5.01M 10-K · filed 2019-04-01 |
| 2017-09-30 | $10.18K 10-Q/A · filed 2018-07-13 |
| 2017-06-30 | $1.01M 10-Q/A · filed 2018-07-13 |
| 2017-03-31 | $157.47K 10-Q · filed 2017-05-15 |
| 2016-12-31 | $50.00K 10-Q/A · filed 2018-07-13 |
| 2016-09-30 | $599.94K 10-Q · filed 2016-11-14 |
| 2016-06-30 | $1.55M 10-Q · filed 2016-08-11 |
| 2016-03-31 | $2.44M 10-Q · filed 2016-05-12 |
| 2015-12-31 | $4.03M 10-K · filed 2017-04-11 |
| 2015-09-30 | $5.23M 10-Q · filed 2015-11-13 |
| 2015-06-30 | $6.42M 10-Q · filed 2015-08-18 |
| 2015-03-31 | $8.06M 10-Q · filed 2015-05-14 |
| 2014-12-31 | $9.26M 10-K · filed 2016-03-30 |
| 2014-09-30 | $10.21M 10-Q · filed 2014-11-13 |
| 2014-06-30 | $11.44M 10-Q · filed 2014-08-12 |
| 2014-03-31 | $12.50M 10-Q · filed 2014-05-14 |
| 2013-12-31 | $0.00 10-Q · filed 2014-11-13 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Cardio Diagnostics Holdings, Inc. (CDIO) | United States | $0.006B | |
| BIOMERICA INC (BMRA) | United States | $0.011B | |
| VOLITIONRX LTD (VNRX) | $0.003B | -0.64 | |
| IMMUCELL CORP /DE/ (ICCC) | United States | $0.091B | 116.10 |
| Insight Molecular Diagnostics Inc. (IMDX) | United States | $0.129B | -3.90 |
| MYRIAD GENETICS INC (MYGN) | United States | $0.397B | -4.84 |
| Alpha Teknova, Inc. (TKNO) | United States | $0.500B | -18.12 |
| QuidelOrtho Corp (QDEL) | United States | $0.733B | -0.90 |
| ACHIEVE LIFE SCIENCES, INC. (ACHV) | United States | $0.806B | -5.88 |
| Intellia Therapeutics, Inc. (NTLA) | United States | $1.705B | -5.92 |